文献速递湿疹皮炎与荨麻疹

特应性皮炎与学业表现:丹麦与英格兰平行队列研究

Atopic Dermatitis and Academic Performance.
PubMed 文献 · JAMA Dermatol · 2026-01-01

该研究基于丹麦全国登记队列(n=776 214)和英格兰Avon亲子纵向研究(n=6 623),分析特应性皮炎(AD)与16岁全国 compulsory 考试成绩的关联。丹麦队列中AD与非AD儿童不及格率(12.0% vs 11.2%;aPR 1.06)和平均成绩差异(-0.06分)均相近,活动性AD不及格率稍高(aPR 1.19);英格兰队列中AD儿童不及格率反而更低(37.7% vs 47.4%;aPR 0.88)。总体提示AD与学业成绩无临床意义的损害。

要点

  • 丹麦队列AD与非AD儿童不及格率相近(12.0% vs 11.2%;aPR 1.06)。
  • 活动性AD与不及格率稍高相关(aPR 1.19;95%CI 1.03-1.37)。
  • 英格兰队列AD儿童不及格率更低(37.7% vs 47.4%;aPR 0.88)。

核心结论

  • 在两个大型队列中,AD与青少年全国 compulsory 考试成绩无临床意义的损害相关。

研究设计与样本

  • 平行人群队列研究:丹麦1986-2000年出生儿童随访至2018年(n=776 214;AD 10 259例)。
  • 英格兰Avon亲子纵向研究1991-1992年出生儿童随访至2009年(n=6 623;AD 2 967例)。
  • 丹麦分析在暴露不一致的全同胞中重复以控制家庭因素。

主要发现

  • 丹麦队列:AD与非AD儿童不及格率12.0% vs 11.2%(aPR 1.06;95%CI 1.01-1.12)。
  • 丹麦队列:AD与非AD儿童平均成绩差异-0.06分(95%CI -0.11至-0.01)。
  • 丹麦队列:活动性AD与不及格率较高相关(aPR 1.19;95%CI 1.03-1.37)。
  • 英格兰队列:AD儿童不及格率37.7% vs 47.4%(aPR 0.88;95%CI 0.83-0.93),平均成绩高10.48分(95%CI 6.49-13.86)。
  • 英格兰队列:中度和中度频繁AD表型解释较好表现,轻度间歇或重度频繁AD与对照相近。

临床怎么用

  • 临床可告知家长:AD本身不预期导致学业成绩显著下降。
  • 对活动性AD儿童可关注学业表现,但无需过度担忧群体层面损害。

局限性

  • AD定义基于医院诊断(丹麦)或母亲报告(英格兰),可能存在错分。
  • 英格兰队列样本量较小且不及格率基线较高,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Atopic dermatitis (AD) may impair school performance through sleep disturbance, comorbidities, or psychosocial effects; however, population-based longitudinal evidence is limited. OBJECTIVE: To investigate the association of AD with academic performance and whether this association is modified or confounded by disease phenotype and socioeconomic background. DESIGN, SETTING, AND PARTICIPANTS: Parallel, population-based cohort studies in Denmark and England, including children with or without AD. In Denmark, children born between 1986 and 2000 from nationwide linked registries were followed up through 2018. In England, children born between 1991 and 1992 from the Avon Longitudinal Study of Parents and Children, linked to the National Pupil Database, were followed up through 2009. Data analysis was conducted from October 2022 to April 2024. EXPOSURES: AD, defined as hospital diagnosis before age 13 years (Denmark) or 2 or more maternal reports of AD by age 11.5 years (England). Danish analyses were repeated in exposure-discordant full siblings to account for family factors. MAIN OUTCOMES AND MEASURES: Academic performance on final compulsory national examinations at approximately age 16 years: nonpassing grade (binary outcome; Poisson regression prevalence ratios) and mean academic performance score (continuous outcome; linear regression mean differences). RESULTS: A total of 782 837 children were included between both studies. In Denmark (n = 776 214; 10 259 children with AD; 386 408 [49.8%] female), the prevalence of nonpassing grades (12.0% vs 11.2%; fully adjusted prevalence ratio [aPR], 1.06 [95% CI, 1.01-1.12]) and mean academic performance scores (fully adjusted mean difference, -0.06 points [95% CI, -0.11 to -0.01]) were similar between children with vs without AD. Active AD was associated with a higher prevalence of nonpassing grades than no AD (aPR, 1.19 [95% CI, 1.03-1.37]). Sibling analyses yielded similar results. In England (n = 6623; 2967 children with AD; 3332 [50.3%] female), nonpassing grades were slightly less common (37.7% vs 47.4%; aPR, 0.88 [95% CI, 0.83-0.93]) and mean performance scores were higher (10.48 points [95% CI, 6.49-13.86]) in children with vs without AD. Phenotype analyses showed that better performance in children with moderate-declining and moderate-frequent AD primarily explained these results, whereas those with mild-intermittent or severe-frequent AD performed similarly to the unaffected or rare comparator. Overall, no consistent variation by disease phenotype or socioeconomic background was found across academic performance outcomes and settings. CONCLUSIONS AND RELEVANCE: In these parallel cohort studies, triangulation across 2 large cohorts and multiple analyses provided reassurance that AD is likely not associated with meaningfully diminished academic performance among adolescents taking national compulsory examinations.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Iskandar RJ, Mailhac A, Mulick A, et al. Atopic Dermatitis and Academic Performance. JAMA Dermatol. 2026. PMID: 41949839. doi:10.1001/jamadermatol.2026.0425

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。